Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020222189 - CRYSTALLINE FORM OF 6-[4-[1-(PROPAN-2-YL)PIPERIDIN-4-YL]-1,4-DIAZEPAN-1-YL]-N-(PYRDIN-4-YL)PYRIDINE-2-CARBOXAMIDE

Publication Number WO/2020/222189
Publication Date 05.11.2020
International Application No. PCT/IB2020/054141
International Filing Date 01.05.2020
IPC
A61P 25/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 401/14 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14containing three or more hetero rings
A61P 27/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61P 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
CPC
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 27/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
A61P 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 401/14
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14containing three or more hetero rings
Applicants
  • PROXIMAGEN, LLC [US]/[US]
Inventors
  • MCTARSNEY, Joseph
  • HILL, Daniel
  • GEYEN, Daren
  • PATIENT, Lee
Agents
  • GILL JENNINGS & EVERY LLP
  • JONES, Ian, Leigh
Priority Data
62/842,15602.05.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CRYSTALLINE FORM OF 6-[4-[1-(PROPAN-2-YL)PIPERIDIN-4-YL]-1,4-DIAZEPAN-1-YL]-N-(PYRDIN-4-YL)PYRIDINE-2-CARBOXAMIDE
(FR) FORME CRISTALLINE DE 6-[4-[1-(PROPAN-2-YL)PIPÉRIDIN-4-YL]-1,4-DIAZÉPAN-1-YL]-N-(PYRDIN-4-YL) PYRIDINE-2-CARBOXAMIDE
Abstract
(EN)
This invention relates to a novel crystalline form of a compound of Formula (I), which is 6-{4-[1 -(propan-2 -yl)piperidin-4-yl]-1,4-diazepan-1 -yl}-N-(pyridin-4- yl)pyridine-2-carboxamide, and pharmaceutical compositions including the crystalline form. It also relates to the uses of such compositions, and to processes for the preparation of the crystalline forms and the compositions.
(FR)
La présente invention concerne une nouvelle forme cristalline d'un composé de formule (I), qui est le 6-{4-[1-(propan-2-yl))pipéridin-4-yl]-1,4-diazépan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide, et des compositions pharmaceutiques comprenant la forme cristalline. L'invention concerne également les utilisations de telles compositions, et des procédés pour la préparation des formes cristallines et des compositions.
Latest bibliographic data on file with the International Bureau